These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 17973862

  • 1. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF, Xiao C, Li H, Yang SJ.
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis.
    Xiao C, Yang BF, Song JH, Schulman H, Li L, Hao C.
    Exp Cell Res; 2005 Mar 10; 304(1):244-55. PubMed ID: 15707589
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
    Song JH, Song DK, Herlyn M, Petruk KC, Hao C.
    Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells.
    Yang BF, Xiao C, Roa WH, Krammer PH, Hao C.
    J Biol Chem; 2003 Feb 28; 278(9):7043-50. PubMed ID: 12496285
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.
    Blomberg J, Ruuth K, Santos D, Lundgren E.
    Anticancer Res; 2008 Feb 28; 28(2A):593-9. PubMed ID: 18506997
    [Abstract] [Full Text] [Related]

  • 13. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
    Abedini MR, Qiu Q, Yan X, Tsang BK.
    Oncogene; 2004 Sep 16; 23(42):6997-7004. PubMed ID: 15258564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
    Park SJ, Kim MJ, Kim HB, Kang CD, Kim SH.
    Biochem J; 2009 Apr 28; 420(1):73-81. PubMed ID: 19203346
    [Abstract] [Full Text] [Related]

  • 16. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P, Song JH, Song DK, Zhang J, Hao C.
    Cell Signal; 2006 Sep 28; 18(9):1528-35. PubMed ID: 16442262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.